| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 46 |
| 1 | METHOTREXATE | 34 |
| 2 | RITUXIMAB | 26 |
| 3 | ADALIMUMAB | 23 |
| 4 | PREDNISONE | 21 |
| 5 | PREDNISOLONE | 20 |
| 6 | PREDNISOLONE ORAL | 20 |
| 7 | PREDNISOLONE ORAL SOLUTION | 20 |
| 8 | DEXAMETHASONE | 18 |
| 9 | DEXAMETHASONE 1.5 MG | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUOCINOLONE ACETONIDE | 7 | 0.0019 |
| 1 | EPCORITAMAB-BYSP | 1 | 0.0007 |
| 2 | NETARSUDIL | 1 | 0.0005 |
| 3 | GOLIMUMAB | 6 | 0.0005 |
| 4 | PREDNISOLONE ACETATE | 5 | 0.0004 |
| 5 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 10 | 0.0004 |
| 6 | CEFTAZIDIME | 3 | 0.0004 |
| 7 | SITAGLIPTIN PHOSPHATE | 1 | 0.0004 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 3 | 0.0004 |
| 9 | MYCOPHENILIC ACID | 7 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 7 | 0.0003 |
| 2 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 27 | 0.0001 |
| 4 | Alkylating Drug [EPC] | 19 | 0.0001 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 34 | 0.0001 |
| 6 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |
| 7 | Janus Kinase Inhibitor [EPC] | 8 | 0.0000 |
| 8 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |